v3.26.1
UNAUDITED CONDENSED CONSOLIDATED INTERIM STATEMENTS OF CASH FLOWS - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities        
Net loss $ (4,269,131) $ (2,653,107) $ (16,543,616) $ (7,908,777)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation 88,588 5,080 36,408 15,319
Amortization of ROU asset 14,761 21,188 88,738 77,383
Unrealized gain on investments (14,867) (11,422) (29,664) (5,474)
Realized gain on investments (107,624) 0 (40,911) (6,881)
Amortization of debt discount 0 117,067 500,937 1,777,505
Change in fair value of derivative liability 0 704,662 970,866 1,642,697
Stock-based compensation 1,796,774 0 6,069,560 0
Loss on disposal of property, plant, and equipment 4,603 0    
Write-off of other receivable     1,064 0
Changes in operating assets and liabilities:        
Accrued interest 0 114,820 516,445 397,517
Accounts payable and accrued liabilities 64,758 (10,388) 234,332 255,194
Due from shareholder (1,526,126) 0    
Deferred income (14,998) 93,740 (195,800) (52,200)
Grant payable 389,000 (40,000) 354,967 0
Prepaid expenses (376,601) 9,789 (96,116) 19,868
Lease liability (12,679) (21,161) (87,749) (75,801)
Due to related party     (6,833) 0
Other receivable     0 (1,064)
Net cash used in operating activities (3,963,542) (1,669,732) (8,227,372) (3,864,714)
Cash flows from investing activities        
Additions to long-term deposits 0 (5,000,000) (5,945,911) (550,000)
Purchase of short-term investments (8,586,239) (295,422) (16,560,779) (1,295,252)
Redemption of short-term investments 10,056,100 0 2,363,696 589,200
Purchase of property and equipment     (150,763) 0
Net cash provided by (used in) investing activities 1,469,861 (5,295,422) (20,293,757) (1,256,052)
Cash flows from financing activities        
Proceeds from private placements 0 4,101,909    
Cash paid for financing costs 0 (232,078) (3,157,638) (841,337)
Repayment of related party notes payable     (100,000) (45,000)
Issuance costs for convertible debentures     0 (19,950)
Proceeds from convertible debentures     0 743,400
Proceeds from Regulation A financing     7,247,931 10,690,243
Proceeds from Initial Public Offering     22,061,857 0
Net cash provided by financing activities 0 3,869,831 26,052,150 10,527,356
Decrease in cash and restricted cash (2,493,681) (3,095,323) (2,468,979) 5,406,590
Cash and restricted cash, beginning of period 4,631,720 7,100,699 7,100,699 1,694,109
Cash and restricted cash, end of period 2,138,039 4,005,376 4,631,720 7,100,699
Cash 1,402,025 3,955,164 4,581,128 7,050,610
Restricted cash 736,014 50,212 50,592 50,089
Total cash and restricted cash, end of period 2,138,039 4,005,376 4,631,720 7,100,699
Supplemental cash flow information        
Income taxes paid 0 0 0 0
Interest paid 0 3,589 39,539 89,152
Supplemental disclosure of non-cash investing and financing activities        
Shares issued for common stock subscribed 0 1,870,643 1,870,643 0
Deferred financing costs recognized as share issuance costs $ 0 $ 105,703 105,703 0
Right of use asset modifications     303,611 0
Right of use asset additions     20,372 0
Notes and interest payable converted into shares     1,451,480 0
Convertible debentures and derivative liabilities converted into shares     13,767,137 0
Initial derivative liability from issuance of convertible notes     $ 0 $ 475,909